Your browser doesn't support javascript.
loading
Erratum to "Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100-116]".
Van Assche, Evelien; Ramos-Quiroga, J Antoni; Pariante, Carmine M; Sforzini, Luca; Young, Allan H; Flossbach, Yanina; Gold, Stefan M; Hoogendijk, Witte J G; Baune, Bernhard T; Maron, Eduard.
Afiliação
  • Van Assche E; Department of Psychiatry, University of Münster, Münster, Germany. Electronic address: Evelien.vanassche@uni-muenster.de.
  • Ramos-Quiroga JA; Department of Psychiatry, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Catalonia, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR
  • Pariante CM; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, London, UK; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
  • Sforzini L; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, London, UK.
  • Young AH; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, London, UK; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
  • Flossbach Y; Neuroscience, Global Drug Development, Novartis Pharma AG, Basel, Switzerland.
  • Gold SM; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Berlin, Germany; Charité - Universitätsmedizin Berlin, Department of Psychosomatic Medicine, Campus Benjamin Franklin, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Institute o
  • Hoogendijk WJG; Department of Psychiatry, Erasmus University Medical Centre, Rotterdam, the Netherlands.
  • Baune BT; Department of Psychiatry, University of Münster, Münster, Germany; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
  • Maron E; Department of Psychiatry, University of Tartu, Tartu, Estonia; Faculty of Medicine, Department of Medicine, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK; Documental Ltd, Tallin, Estonia; West Tallinn Central Hospital, Tallinn, Estonia.
Eur Neuropsychopharmacol ; 63: 4-5, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35896050
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Neuropsychopharmacol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Neuropsychopharmacol Ano de publicação: 2022 Tipo de documento: Article